New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Nutex Health, Inc.
NUTX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

304M

Medical - Healthcare Information Services

Next Earning date - 27 Mar 2025

304M

Medical - Healthcare Information Services

Next Earning date - 27 Mar 2025

55.90USD

Shape0.88 ( 1.60%)
Market Closed (as of Mar 18, 20:00 EDT)
favorite-chart

Relative Strenght

97
favorite-chart

Volume Buzz

-12%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

20%

Quote Panel

Shape
Updated March 19, 2025
1W 22.37 % 1M -9.33 % 3M 90.27 % 1Y 259.25 %

Key Metrics

Shape
  • Market Cap

    303.93M


  • Shares Outstanding

    5.44M


  • Share in Float

    3.26M


  • Dividende

    0


  • Earning Date

    27 Mar 2025


  • Price Target

    55.9


  • Average Volume

    40737


  • Beta

    2.222


  • Range

    4.16-69.45


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.nutexhealth.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

NUTX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$347M

Shape341%

2025-Revenue

$1.24

Shape100%

2025-EPS

$41M

Shape-631%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Maxim Group

initialise

Previous: Not converted

2024-09-18

Now: Buy

Benchmark

initialise

Previous: Not converted

2022-12-23

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-3.00
vs 0.38

Q1.23

arrow
arrow

N/A

-1.50
vs -0.42

Q2.23

arrow
arrow

N/A

-1.50
vs -4.50

Q3.23

arrow
arrow

N/A

-1.50
vs -3.00

Q4.23

arrow
arrow

N/A

-7.50
vs -3.00

Q1.24

arrow
arrow

N/A

-0.10
vs -1.50

Q2.24

arrow
arrow

N/A

-0.07
vs -1.50

Q3.24

arrow
arrow

N/A

-1.72
vs -1.50

Q4.24

arrow
arrow

N/A

-0.12
vs -7.50

Q1.25

arrow
arrow

N/A

-0.24
vs -0.10

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-17%

53.7M  vs 65M

Q1.23

arrow
arrow

+807%

56.3M  vs 6.2M

Q2.23

arrow
arrow

+2%

58.9M  vs 58M

Q3.23

arrow
arrow

+121%

62.7M  vs 28.4M

Q4.23

arrow
arrow

+30%

69.7M  vs 53.7M

Q1.24

arrow
arrow

+20%

67.5M  vs 56.3M

Q2.24

arrow
arrow

+29%

76.1M  vs 58.9M

Q3.24

arrow
arrow

+26%

78.8M  vs 62.7M

Q4.24

arrow
arrow

+16%

81.1M  vs 69.7M

Q1.25

arrow
arrow

+21%

81.8M  vs 67.5M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-11%

-0.11
vs -3.92

Q1.23

arrow
arrow

-6%

-0.06
vs -0.11

Q2.23

arrow
arrow

-4%

-0.04
vs -0.06

Q3.23

arrow
arrow

-6%

-0.06
vs -0.04

Q4.23

arrow
arrow

-51%

-0.51
vs -0.06

Q1.24

arrow
arrow

-1%

-0.01
vs -0.51

Q2.24

arrow
arrow

-1%

-0.01
vs -0.01

Q3.24

arrow
arrow

-14540%

-145.40
vs -0.01

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

50

50
vs 48

4%

Q4.22

arrow
arrow

77

77
vs 50

54%

Q1.23

arrow
arrow

84

84
vs 77

9%

Q2.23

arrow
arrow

74

74
vs 84

-12%

Q3.23

arrow
arrow

58

58
vs 74

-22%

Q4.23

arrow
arrow

49

49
vs 58

-16%

Q1.24

arrow
arrow

43

43
vs 49

-12%

Q2.24

arrow
arrow

2

2
vs 43

-95%

Earnings Growth

Latest News